APOE and Alzheimer disease: By contrast, among clinically and neuropathologically confirmed AD cases and controls of European ancestry, a single copy of the APOE ε2 allele is associated with 0.61-fold decreased risk and ε2 homozygotes have an 0.87-fold reduced risk for AD compared to individuals with the ε3/ε3 genotype [12].